As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. The offer price, representing a 30% premium to the stock's ...

Expert Systems announced a significant milestone in a development of Traws Pharma’s (TRAW) H5N1 antiviral program. The investigational drug, ...

Jefferies analyst Dennis Ding maintained a Hold rating on Crinetics Pharmaceuticals (CRNX – Research Report) today and set a price target of ...

The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...

Ukraine's long-range drone strikes on airbases and ammunition depots inside Russia have reduced the glide-bomb threat.

Innovation in the sector is driven by the healthcare industry's advancements, shaped by emerging therapeutic modalities and ...

Bill Detwiler of Celonis shares how Process Intelligence can deliver insights into juvenile justice, which can drive policy ...

OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...

You won’t hear laundry and dish pod trailblazer Dropps on its soap box about sustainable packaging. Its new paperboard soap ...

Combining a premade SMN protein with a Spinraza-like drug (targets SMN2 gene) helped patient-derived motor neurons; potential ...